Regulation of Platelet Activation and Coagulation: Current Concepts, Novel Targets, and Therapies

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Thrombosis Research

Background:

• Antiplatelet and anticoagulant therapies are crucial for secondary prevention in high-risk cardiovascular patients.
• Historically, the focus was on antithrombotic efficacy, but current guidelines emphasize a balanced approach including bleeding risk.
• Individualized therapy considers drug type, strength, combination, and duration to manage bleeding risk.

Purpose of the Study:

• To review established drug targets and pharmacological approaches for antiplatelet and anticoagulant therapies.
• To provide an overview of novel agents in development for high-risk cardiovascular patients.
• To highlight the shift towards individualized therapy balancing efficacy and safety.

Main Methods:

• Literature review of recent trials and guidelines.
• Analysis of established and emerging antiplatelet and anticoagulant drug classes.
• Evaluation of factors influencing individual bleeding risk.

Main Results:

• Current strategies focus on balancing antithrombotic effects with bleeding risk for personalized cardiovascular secondary prevention.
• Novel antiplatelet and anticoagulant agents are emerging with potential for improved safety profiles.
• Understanding drug interactions and patient-specific factors is key to optimizing therapy.

Conclusions:

• Individualized antiplatelet and anticoagulant therapy is essential for high-risk cardiovascular patients.
• Future pharmacologic developments promise safer and more effective treatment options.
• Ongoing research is critical to refine therapeutic strategies and minimize bleeding complications.